Relevant bibliographies by topics / Hepatobiliary system

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Hepatobiliary system'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 May 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatobiliary system.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatobiliary system"

1

Taylor, K. J. W. "Hepatobiliary system." Ultrasound in Medicine & Biology 26 (May 2000): S71—S72. http://dx.doi.org/10.1016/s0301-5629(00)00169-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

GONZALEZ-BROWN, VERONICA, and HEATHER A. FREY. "The Hepatobiliary System." Clinical Obstetrics and Gynecology 63, no. 1 (March 2020): 122–33. http://dx.doi.org/10.1097/grf.0000000000000504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hynes, Daniel, Christina Duffin, and Tara Catanzano. "Infections of the Hepatobiliary System." Seminars in Ultrasound, CT and MRI 41, no. 1 (February 2020): 46–62. http://dx.doi.org/10.1053/j.sult.2019.10.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Farrell, Frank J., and Emmet B. Keeffe. "DIABETES AND THE HEPATOBILIARY SYSTEM." Clinics in Liver Disease 2, no. 1 (February 1998): 119–31. http://dx.doi.org/10.1016/s1089-3261(05)70367-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Masyuk, Anatoliy I., and Nicholas F. LaRusso. "Aquaporins in the hepatobiliary system." Hepatology 43, S1 (2006): S75—S81. http://dx.doi.org/10.1002/hep.20996.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Maksimak, Martin, Elaine Wilt, A. Thompson Colley, and Archimedes Garbes. "Hemangioendothelioma of the Hepatobiliary System." Journal of Pediatric Gastroenterology and Nutrition 10, no. 1 (January 1990): 131–37. http://dx.doi.org/10.1097/00005176-199001000-00026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Brown, Rachel M., and Stefan G. Hübscher. "Infectious diseases of the hepatobiliary system." Diagnostic Histopathology 19, no. 3 (March 2013): 80–88. http://dx.doi.org/10.1016/j.mpdhp.2013.01.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brown, Rachel M. "Infectious diseases of the hepatobiliary system." Diagnostic Histopathology 23, no. 9 (September 2017): 405–13. http://dx.doi.org/10.1016/j.mpdhp.2017.07.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Brown, Rachel Mary. "Infectious diseases of the hepatobiliary system." Diagnostic Histopathology 26, no. 12 (December 2020): 566–74. http://dx.doi.org/10.1016/j.mpdhp.2020.10.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Benson, Mark D., and Mitesh R. Gandhi. "Ultrasound of the Hepatobiliary-pancreatic System." World Journal of Surgery 24, no. 2 (February 2000): 166–70. http://dx.doi.org/10.1007/s002689910029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hepatobiliary system"

1

Crafer, Shelagh M. d'O. "Aspects of transport in the hepatobiliary system." Thesis, University of East Anglia, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.304553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dahlström, Nils. "Magnetic Resonance Imaging of the Hepatobiliary System Using Hepatocyte-Specific Contrast Media." Licentiate thesis, Linköping University, Linköping University, Linköping University, Radiology, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-17918.

Full text
Abstract:

There are two Gadolinium-based liver-specific contrast media for Magnetic Resonance Imaging on the market, Gd-BOPTA (MultiHance®, Bracco Imaging, Milan, Italy) and Gd-EOB-DTPA (Primovist®, Bayer Schering Pharma, Berlin, Germany). The aim of this study in two parts was to evaluate the dynamics of biliary, parenchymal and vascular enhancement using these contrast media in healthy subjects. Ten healthy volunteers were examined in a 1.5 T magnetic resonance system using three-dimensional Volumetric Interpolated Breath-Hold (VIBE) sequences for dynamic imaging with both contrast media – at two different occasions – until five hours after injection. The doses given were 0.025 mmol/kg for Gd-EOB-DTPA and 0.1 mmol/kg for Gd-BOPTA. The enhancement over time of the common biliary duct in contrast to the liver parenchyma was analyzed in the first study. This was followed by a study of the image contrasts of the hepatic artery, portal vein and middle hepatic vein versus the liver parenchyma.While Gd-EOB-DTPA gave an earlier and more prolonged enhancement of the biliary duct, Gd-BOPTA achieved higher image contrast for all vessels studied, during the arterial and portal venous phases. There was no significant difference in the maximal enhancement obtained in the liver parenchyma.At the obtained time-points and at the dosage used, the high contrast between the common biliary duct and liver parenchyma had an earlier onset and longer duration for Gd-EOB-DTPA, while Gd-BOPTA achieved higher maximal enhancement of the hepatic artery, portal vein and middle hepatic vein than Gd-EOB-DTPA. Diseases of the liver and biliary system may affect the vasculature, parenchyma, biliary excretion or a combination of these. The clinical context regarding the relative importance of vascular, hepatic parenchymal and biliary processes should determine the choice of contrast media for each patient and examination.

 

APA, Harvard, Vancouver, ISO, and other styles
3

Dahlström, Nils. "Magnetic resonance imaging of the hepatobiliary system using hepatocyte-specific contrast media /." Linköping : Department of Medical and Health Sciences, Linköping University, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-17918.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Мелеховець, Оксана Костянтинівна, Оксана Константиновна Мелеховец, Oksana Kostiantynivna Melekhovets, Рім Су Нг'є Шу, Д. О. Тичина, І. М. Закорко, А. В. Ковчун, А. В. Котков, and В. І. Євдокименко. "Особливості корекції тиреоїдної дисфункції при порушеннях гепатобіліарної системи." Thesis, Сумський державний університет, 2013. http://essuir.sumdu.edu.ua/handle/123456789/32768.

Full text
Abstract:
При порушенні тиреоїдного гомеостазу у хворих на гіпотиреоз виявляються ознаки функціональних розладів жовчовивідної системи. Дослідження показують, що навіть при мінімальній тиреоїдній недостатності відбувається збільшення частоти розвитку дискінезій біліарного тракту за гіпотонічним типом з явищами холестазу. При цитуванні документа, використовуйте посилання http://essuir.sumdu.edu.ua/handle/123456789/32768
APA, Harvard, Vancouver, ISO, and other styles
5

Perepichka, M. P. "Evaluation of condition of the hepatobiliary system organs in patients with different clinical signs of rosacea." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18886.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dahlström, Nils. "Quantitative Evaluation of Contrast Agent Dynamics in Liver MRI." Doctoral thesis, Linköpings universitet, Centrum för medicinsk bildvetenskap och visualisering, CMIV, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-60264.

Full text
Abstract:
The studies presented here evaluate the biliary, parenchymal and vascular enhancement effects of two T1-shortening liver-specific contrast agents, Gd-BOPTA and Gd-EOB-DTPA, in Magnetic Resonance Imaging (MRI) of healthy subjects and of patients. Ten healthy volunteers were examined with both contrast agents in a 1.5 T MRI system using three-dimensional gradient echo sequences for dynamic imaging until five hours after injection. The enhancement of the common hepatic duct in contrast to the liver parenchyma was analyzed in the first study. This was followed by a study of the image contrasts of the hepatic artery, portal vein and middle hepatic vein versus the liver parenchyma. While Gd-EOB-DTPA gave an earlier and more prolonged enhancement and image contrast of the bile duct, Gd-BOPTA achieved higher maximal enhancement and higher image contrast for all vessels studied during the arterial and portal venous phases. There was no significant difference in the maximal enhancement obtained in the liver parenchyma. In a third study, another 10 healthy volunteers were examined with the same protocol in another 1.5 T MRI system. Using signal normalization and a more quantitative, pharmacokinetic analysis, the hepatocyte-specific uptake of Gd-EOB-DTPA and Gd-BOPTA was calculated. A significant between-subjects correlation of the uptake estimates was found and the ratio of these uptake rates was of the same magnitude as has been reported in pre-clinical studies. The procedure also enabled quantitative analysis of vascular enhancement properties of these agents. Gd-BOPTA was found to give higher vessel-to-liver contrast than Gd-EOB-DTPA when recommended doses were given. In the final study, retrospectively gathered datasets from patients with hepatobiliary disease were analyzed using the quantitative estimation of hepatic uptake of Gd-EOB-DTPA described in the third study. The uptake rate estimate provided significant predictive ability in separating normal from disturbed hepatobiliary function, which is promising for future evaluations of regional and global liver disease. In conclusion, the differing dynamic enhancement profiles of the liver-specific contrast agents presented here can be beneficial in one context and challenging in another. Diseases of the liver and biliary system may affect the vasculature, parenchyma or biliary excretion, or a combination of these. The clinical context in terms of the relative importance of vascular, hepatic parenchymal and biliary processes should therefore determine the contrast agent for each patient and examination. A quantitative approach to analysis of contrast-enhanced liver MRI examinations is feasible and may prove valuable for their interpretation.
APA, Harvard, Vancouver, ISO, and other styles
7

Marí, Alfonso Begoña. "Esclerosis sistémica y enfermedad hepato-biliar: Estudio bidireccional de la relación entre la esclerosis sistémica y la enfermedad hepato-biliar." Doctoral thesis, Universitat Autònoma de Barcelona, 2018. http://hdl.handle.net/10803/665453.

Full text
Abstract:
La esclerosis sistémica (ES) es una enfermedad autoinmune sistémica (EAS) que puede afectar a la mayoría de órganos internos mediante la acumulación de colágeno en los tejidos y/o desarrollo de una vasculopatía obliterante, en un entorno de disfunción autoinmune. Aunque la disfunción hepato-biliar (DHB) no es un hallazgo infrecuente en la ES, su presencia no se considera característica de la enfermedad y se han publicado pocos estudios que valoren la relación bidireccional entre la ES y la DHB, en particular autoinmune órgano-específica. El primer artículo de esta Tesis doctoral es un estudio observacional multicéntrico Español de 1572 pacientes con ES y como objetivos establece la prevalencia de DHB en pacientes con ES y enumera las causas que son predominantemente autoinmunes órgano-específicas, como la colangitis biliar primaria (CBP) en 4.3% y la hepatitis autoinmune en 1.2% y CBP sin anticuerpos antimitocondria en 0.4%.. La presencia de DHB en pacientes con ES se asocia independientemente a un menor riesgo de padecer una ES cutánea difusa y a una mayor prevalencia de calcinosis cutánea, disfunción diastólica de ventrículo izquierdo, síndrome seco y positividad de los anticuerpos anticentrómero (ACA). La presencia de DHB no influyó en la supervivencia. Según los subtipos cutáneos, la DHB se asocia a: 1) en pacientes con ES cutánea limitada, a un mayor tiempo desde el inicio de la ES hasta su diagnóstico y a una mayor prevalencia de síndrome seco y presencia de ACA; 2) en pacientes con ES sine escleroderma, a una mayor prevalencia de síndrome seco, y 3) en pacientes con ES cutánea difusa, no se identificó ningún rasgo diferencial con respecto a los pacientes sin DHB. El segundo artículo es un estudio observacional que reclutó una cohorte de 62 pacientes con CBP a los que se aplicó un protocolo de estudio dirigido a determinar la prevalencia de EAS asociada a esta entidad. Los resultados muestran que la prevalencia de EAS en pacientes con CBP es del 35.4%. La ES es la entidad más frecuentemente diagnosticada (21%), en particular del subtipo cutáneo limitado (11%). Los ACA son el único parámetro inmunológico identificado con mayor frecuencia en pacientes con CBP y EAS. Los pacientes con CBP-EAS tienen más prevalencia de manifestaciones extrahepáticas como fenómeno de Raynaud, síndrome seco, telangiectasias, artritis y disnea, así como una asociación significativa a ACA y alteraciones capilaroscópicas sugestivas de ES, que pueden ser factores predictores de la asociación de ambas enfermedades. Por estos motivos, recomendamos el empleo de un protocolo de valoración clínica, inmunológica y de una capilaroscòpia periungueal.
Systemic sclerosis (SSc) is a chronic autoimmune systemic disease (ASD) that may affect most internal organs caused by an accumulation of collagen in tissues and/or the development of obliterative vasculopathy in the context of autoimmune dysfunction. Although liver disturbance is not a rare finding in SSc, its presence is not considered characteristic of this disease and few studies have assessed the bidirectional relationship between SSc and hepatobiliary dysfunction (HBD), especially addressed to investigating organ-specific diseases. The first article of this doctoral thesis is a Spanish multicenter observational study including 1572 patients with SSc that establishes the prevalence of HBD in patients with SSc at 7.5% and the main causes as organ-specific autoimmune diseases, such as primary biliary cholangitis (PBC) at 4.3%, autoimmune hepatitis at 1.2% and PBC without antimitochondrial antibodies at 0.4%. The presence of HBD in patients with SSc is independently associated with a lower risk of developing diffuse cutaneous SSc and a greater prevalence of cutaneous calcinosis, diastolic dysfunction of left ventricle, Sicca syndrome and positive anticentromere antibodies. The presence of HBD did not influence survival. According to cutaneous subtypes, HBD is associated with: 1) In patients with limited cutaneous SS, a longer time-to-diagnosis since SSc onset to its diagnosis and a greater prevalence of sicca syndrome and presence of anticentromere antibodies; 2) In patients with SSc sine scleroderma, a greater prevalence of sicca syndrome, and 3) In patients with diffuse cutaneous SSc, no distinguishing feature was identified compared to patients without HBD. The second article is an observational study recruiting a cohort of 62 patients with PBC included in a study protocol to determine the prevalence of ASD associated to this entity. The results obtained show that the prevalence of ASD in patients with PBC is 35.4%. SSc is the most prevalent condition (21%), especially in the limited cutaneous subtype (11%). Anticentromere antibodies are the only immunological parameter most frequently identified in patients with PBC and ASD. Patients with PBC-ASD present extrahepatic manifestations such as Raynaud`s phenomenon, sicca syndrome, telangiectases, arthritis and dyspnea, as well as a significant association of anticentromere antibodies and capillaroscopic alterations suggestive of SSc, which may be predictive factors for the association between both diseases. Consequently, we recommend the use of a protocol for clinical and immunological assessment and periungueal capillaroscopy.
APA, Harvard, Vancouver, ISO, and other styles
8

Saloum, Alaa. "Bridging inflammatory bowel diseases and hepatobiliary disorders through pathway enrichment and module-based approach." Thesis, Högskolan i Skövde, Institutionen för biovetenskap, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18597.

Full text
Abstract:
Inflammatory bowel diseases (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC) are associated with various hepatobiliary disorders. Two of the chronic hepatobiliary disorders that may coexist with inflammatory bowel diseases are: primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Previous studies have hypothesized that IBD, PBC, and PSC might share an underlying mechanism which contributes to the pathogenesis of the three conditions. In this study, a module-based network analysis and pathway enrichment analysis was applied on IBD, PSC, and PBC differentially expressed genes (DEGs). The sample data were obtained from the study by Ostrowski et al. (2019). A network module-based approach was applied to examine generated results where additional information about biological processes, pathways and molecular functions can be inferred. FunRich and Enrichr were utilized as functional enrichment tools. A protein interaction network was constructed for the three conditions using STRING. Functional modules and overlapping modules of IBD, PSC, and PBC were identified using different plug-ins in Cytoscape. Some of the results were consistent with the findings of Ostrowski et al. (2019) such as the ATP synthesis and signal transduction that is shared among the overlapping genes in IBD, PBC, and PSC. ModuLand highlighted nodes that have been previously reported to have a role in the pathogenesis of autoimmune diseases. The proposed approach demonstrated that the module-based approach contributes to similar results regarding biological processes and pathway enrichment of generated modules, compared to enrichment analysis of DEGs. In addition, the utilization of the ModuLand plug-in to find hierarchal layers of disease genes is still poorly researched and would benefit from more in-depth comparison with related tools for module discovery. For instance, implementing ModuLand plug-in can potentially support research in elucidating complex diseases.
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Feng-Chieh, and 李峰杰. "Applications of In Vivo Multiphoton Imaging In Elucidating Biophysical Phenomena of the Hepatobiliary System." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/31388545386811545941.

Full text
Abstract:
博士
臺灣大學
物理研究所
98
Liver, the largest internal organ, is a major chemical factory in the body responsible for important functions such as metabolism, detoxification, nutrient storage, and serum protein production. Traditionally, the study of the liver depended heavily on histological techniques, which are limited to ex-vivo observations and lack dynamic information of the hepatobiliary system. In order to study hepatic metabolism in vivo, we have designed a hepatic imaging chamber made of biocompatible titanium alloy (6V4Al-Ti). Combining the chamber with multiphoton microscopy, we were able to monitor and quantitatively analyze the hepatobiliary metabolism to single cell resolution in vivo. In addition to studying metabolic dynamics, we applied our methodology to investigate mechanism of cell-death. We found that and determined a critical limit for hepatocyte death. We further developed a model based on first order rate equation to model the observed variation of 6-CFDA fluorescence intensity with time and estimate the metabolic capability of hepatocytes. Specifically, we found that zonal difference in the metabolic activity can be revealed by the distribution of the model parameters. Our approach allows the intravital observation of hepatic activities such as acetaminophen (APAP), common bile duct ligation (CBDL), Lipopolysaccharides (LPS), and CCl4. This thesis demonstrated that intravital multiphoton imaging could be used to reveal and quantify metabolic changes in the mouse liver and its potential application in studying many liver disorders.
APA, Harvard, Vancouver, ISO, and other styles
10

許瑞昇. "Preclinical Evaluation of Fe-5-C2H5-EHPG as a Contrast Agent in MR Imaging of Hepatobiliary System." Thesis, 1994. http://ndltd.ncl.edu.tw/handle/20101582242167494973.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Hepatobiliary system"

1

Matos, Celso, and Nickolas Papanikolaou, eds. Diffusion Weighted Imaging of the Hepatobiliary System. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-62977-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lillemoe, Keith D., and Jarnagin William R. Hepatobiliary and pancreatic surgery. Philadelphia: Lippincott Williams & Wilkins, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

D, Sitrin Michael, and Black Dennis D, eds. Gastrointestinal, hepatobiliary, and nutritional physiology. Philadelphia: Lippincott-Raven, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brooke, Jeffrey R., and Tublin Mitchell E, eds. Specialty imaging: Hepatobiliary & pancreas. Salt Lake City: Amirsys Pub., 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lillemoe, Keith D., and Jarnagin William R. Hepatobiliary and pancreatic surgery. Philadelphia: Lippincott Williams & Wilkins, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fluorescent imaging: Treatment of hepatobiliary and pancreatic diseases. Basel: Karger, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

K, Messmer, and Menger M. D, eds. Liver microcirculation and hepatobiliary function: 11th Bodensee Symposium on Microcirculation, Bad Schachen, June 25-28, 1992. Basel: Karger, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

G, Paumgartner, Stiehl A. 1941-, and Gerok W. 1926-, eds. Bile acids and the hepatobiliary system: From basic science to clinical practice : proceedings of the 68th Falk Symposium held in Basel, Switzerland, October 12-14, 1992. Dordrecht: Kluwer Academic Publishers, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Crafer, Shelagh M. d'O. Aspects of transport in the hepatobility system. Norwich: University of East Anglia, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

S, Chamberlain Ronald, and Blumgart L. H, eds. Hepatobiliary surgery. Georgetown, TX: Landes Bioscience, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Hepatobiliary system"

1

Gwaltney-Brant, Sharon. "Hepatobiliary System." In Small Animal Toxicology Essentials, 99–104. West Sussex, UK: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118785591.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bisker, Jeffrey. "Hepatobiliary System." In Clinical Applications of Medical Imaging, 17–35. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5083-5_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Elgazzar, Abdelhamid H., and Ismet Sarikaya. "Hepatobiliary System." In Nuclear Medicine Companion, 203–17. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76156-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lecumberri, F. J., J. I. Bilbao, J. M. Longo, and M. Muñoz. "Diagnostic Imaging of the Hepatobiliary System." In Hepatobiliary Diseases, 117–39. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76802-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brown, Stuart C., and S. Kim Suvarna. "Gastrointestinal and Hepatobiliary System." In Atlas of Adult Autopsy, 161–90. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-27022-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Elgazzar, Abdelhamid H. "Digestive and Hepatobiliary System." In A Concise Guide to Nuclear Medicine, 31–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-19426-9_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Holliman, John H., Daniel L. Feeback, and Nancy K. Hall. "Pancreas and Hepatobiliary system." In Oklahoma Notes, 128–41. New York, NY: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-0322-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hall, Nancy K., and Daniel L. Feeback. "Pancreas and Hepatobiliary System." In Oklahoma Notes, 148–67. New York, NY: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-0502-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Holliman, John H. "Hepatobiliary System and Exocrine Pancreas." In Oklahoma Notes, 147–62. New York, NY: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4684-0435-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brown, Danielle L. "Immunopathology of the Hepatobiliary System." In Immunopathology in Toxicology and Drug Development, 329–417. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47385-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hepatobiliary system"

1

AL-Marzoqi, Galal, Marco Alfonse, Ibrahim F. Moawad, and Mohamed Roushdy. "Web Service-based System for Hepatobiliary System Diseases Prognosis and Treatment." In 2018 13th International Conference on Computer Engineering and Systems (ICCES). IEEE, 2018. http://dx.doi.org/10.1109/icces.2018.8639324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

AL Marzoqi, Galal, Marco Alfonse, Ibrahim F. Moawad, and Mohamed Roushdy. "A survey on Applying Ontological Engineering Approach for Hepatobiliary System Diseases." In The 7th International Conference on Information Technology. Al-Zaytoonah University of Jordan, 2015. http://dx.doi.org/10.15849/icit.2015.0071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sakhno, T. A., M. P. Semenenko, and V. N. Grin. "DYNAMICS OF BIOCHEMICAL INDICATORS OF BLOOD IN FRESH COWS ON THE BACKGROUND OF HEPATOPROTECTOR APPLICATION." In "International Scientific and Practical Conference" THEORY AND PRACTICE OF VETERINARY PHARMACY, ECOLOGY AND TOXICOLOGY IN AIC ", dedicated to the centenary of the Department of Pharmacology and Toxicology, SPbSUVM. FSBEI HE St. Petersburg SUVM, 2021. http://dx.doi.org/10.52419/3006-2021-2-211-212.

Full text
Abstract:
The influence of a new injectable hepatoprotective drug livasen in the prevention of hepatosis in highly productive fresh cows has been studied. The performed pharmacoprophylaxis has shown high efficiency in the correction of diseases of the hepatobiliary system and metabolic insufficiency.
APA, Harvard, Vancouver, ISO, and other styles
4

Xu, Cheng, Jun Jiang, Le Xie, and Xionghui Zhou. "Design of a minimal invasive robot system for hepatobiliary and pancreatic surgery." In 2019 IEEE International Conference on Real-time Computing and Robotics (RCAR). IEEE, 2019. http://dx.doi.org/10.1109/rcar47638.2019.9044015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lin, Chih-Ju, Ning Kang, Jian-Ye Lee, Hsuan-Shu Lee, and Chen-Yuan Dong. "In vivo multiphoton imaging and quantification of cytoplasmic and nuclear metabolism in the hepatobiliary system." In SPIE BiOS, edited by Ammasi Periasamy, Peter T. C. So, Karsten König, and Xiaoliang S. Xie. SPIE, 2017. http://dx.doi.org/10.1117/12.2254944.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Froghi, Saied, Arjan Singh Sehmbi, Matheus de Andrade, Nader Saffari, Barry Fuller, Alberto Quaglia, and Brian Davidson. "P189 Role of high intensity focused ultrasound (HIFU) in treating cancerous lesions of the hepatobiliary system." In Abstracts of the BSG Campus, 21–29 January 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2020-bsgcampus.264.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kolosov, Victor, Igor Gorikov, and Leonid Nakhamchen. "Status of the hepatobiliary system in women of childbearing age with acute bronchitis, caused influenza A(H1N1)swl." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2607.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Accumulation of oxidative hepatobiliary lesions during experimental opisthorchiasis." In Bioinformatics of Genome Regulation and Structure/ Systems Biology. institute of cytology and genetics siberian branch of the russian academy of science, Novosibirsk State University, 2020. http://dx.doi.org/10.18699/bgrs/sb-2020-340.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hayashi, Y., R. Setiono, and K. Yoshida. "Diagnosis of hepatobiliary disorders using rules extracted from artificial neural networks." In Proceedings of 8th International Fuzzy Systems Conference. IEEE, 1999. http://dx.doi.org/10.1109/fuzzy.1999.793263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Igarashi, Toshiharu. "Medi-Torch: A New Framework for User-friendly Hepatobiliary Cancer Guidelines for Patients." In CHI '20: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3334480.3381438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hepatobiliary system' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography